Assessment of Quality of Life of Diabetic Dyslipidemic Patients with Cardiovascular Disease

The incidence of cardiovascular disease is more common in patients with diabetes than in the general population. Dyslipidemia, the clinically proven risk factor for cardiovascular disease is noticeable common in patients with Type 2 diabetes. Recent studies show that most of the dyslipidemic patients were anxious about getting CHD. It is also suggested that future studies should be undertaken to minimise anxiety in this patients. Thus quality of life assessment is now a days considered essential in cardiovascular disease patients inorder to implement early intervention strategies based on life style changes and beginning of an effective lipid lowering therapy which will help in preventing the future development of any CVD complication. Thus it improve quality of life in this high risk population. An effective patient counselling helps in increasing the disease and therapy related knowledge of the patient and help them in better control of their health condition. Health related quality of life is a multidimen ional concept that refers to function and well-being on various dimensions of health. Inorder to assess the different aspects of HRQoL, use of multi instrument is required. Applying a questionnaire along with the study disease can be a useful method measuring HRQoL. The SF-12v2 Health Survey (SF-12v2) is a multipurpose, short-form health survey with 12 questions that yields an eight-scale profile of functional health and well-being, as well as two psychometrically based physical and mental health summary measures and a preference-based health utility index.